MEDICAL MARIJUANA, INC. INVESTMENT AXIM® BIOTECHNOLOGIES, INC. PUBLISHES PRODUCT PIPELINE CHART FOR PHARMA CLINICAL TRIALS PROGRAM IN CANNABINOID R&D

MEDICAL MARIJUANA, INC. INVESTMENT AXIM® BIOTECHNOLOGIES, INC. PUBLISHES PRODUCT PIPELINE CHART FOR PHARMA CLINICAL TRIALS PROGRAM IN CANNABINOID R&D

Cannabinoid Innovator’s Product Pipeline Highlights Timelines of Its Intellectual Property (IP) Protected Cannabinoid-Based Products from Pre-Clinical to NDA for Multiple Indications    NEW YORK – Nov. 3, 2016 – Medical Marijuana, Inc. (OTC: MJNA) today announced that...
Medical Marijuana, Inc. CEO Interviewed for Uptick Newswire; Discusses Latin Market Expansion, Portfolio Companies Kannaway and AXIM Biotech

Medical Marijuana, Inc. CEO Interviewed for Uptick Newswire; Discusses Latin Market Expansion, Portfolio Companies Kannaway and AXIM Biotech

San Diego, CA – Aug. 4, 2016 – Medical Marijuana, Inc. (OTC: MJNA) announced today that the Company’s CEO Dr. Stuart Titus was interviewed by the Uptick Network’s Stock Day Radio Show about expanding access to cannabidiol (CBD)-based products to people across Latin...